Schalch D S, Parlow A F, Boon R C, Reichlin S
J Clin Invest. 1968 Mar;47(3):665-78. doi: 10.1172/JCI105762.
The recent isolation of highly purified human pituitary luteinizing hormone (LH) has permitted the development of a sensitive and specific radioimmunoassay for this hormone in plasma. Results of this immunoassay system employing anti-LH serum agree closely with previous reports for the measurement of plasma LH in which immunoassays employing cross-reactive antisera to human chorionic gonadotropin were used. The immunoassay and bioassay of LH in several crude and partially purified pituitary and urinary extracts show acceptable agreement. The sensitivity of the LH immunoassay (0.2 mmug/ml) is adequate to measure LH levels in almost half of all prepuberal children and in all but a few normal adults. A small, but significant, rise in plasma LH level occurs at pubescence in both boys and girls. In women, plasma LH level varies with both age and the phase of the menstrual cycle. The mean LH concentration in nine normal women during the follicular phase (1.2 mmug/ml was found to be significantly higher than during the luteal phase (1.0 mmug/ml). At midcycle, the mean peak LH level was 10.2 mmug/ml. In a large group of normal women, the mean plasma LH concentration rose significantly at menopause to a level of 5.8 mmug/ml during the fifth decade and 10.5 mmug/ml during the seventh decade. A small, but significant, rise in plasma LH concentration also occurred in men from the third and fourth decades (0.7 mmug/ml to the seventh and eighth decades (1.7 mmug/ml). Both estrogen and testosterone suppress plasma LH levels, but marked variation in response exists. The immunoassay serves as a useful diagnostic tool in evaluating men with gonadal failure, amenorrheic women of reproductive age, and postmenopausal women suspected of hypopituitarism. From the half-time disappearance of LH-(131)I in plasma (mean 69 min) and the calculated volume of distribution (2.5-2.8 liters) it has been determined that approximately 30 mug of LH is secreted per day in men, and in women except at midcycle, at which time the release of LH is estimated to be 10-15 times this basal rate.
最近高度纯化的人垂体促黄体生成素(LH)的分离,使得能够开发出一种用于检测血浆中该激素的灵敏且特异的放射免疫测定法。采用抗LH血清的这种免疫测定系统的结果,与先前使用对人绒毛膜促性腺激素具有交叉反应性抗血清的免疫测定法来测量血浆LH的报告结果非常一致。对几种粗制和部分纯化的垂体及尿液提取物中的LH进行免疫测定和生物测定,结果显示出可接受的一致性。LH免疫测定法的灵敏度(0.2毫微克/毫升)足以测量几乎一半青春期前儿童以及除少数正常成年人外所有成年人的LH水平。在青春期,男孩和女孩的血浆LH水平都会出现小幅但显著的升高。在女性中,血浆LH水平随年龄和月经周期阶段而变化。发现9名正常女性在卵泡期的平均LH浓度(1.2毫微克/毫升)显著高于黄体期(1.0毫微克/毫升)。在月经周期中期,LH的平均峰值水平为10.2毫微克/毫升。在一大群正常女性中,平均血浆LH浓度在绝经时显著升高,在第五个十年达到5.8毫微克/毫升,在第七个十年达到10.5毫微克/毫升。男性从第三个和第四个十年(0.7毫微克/毫升)到第七个和第八个十年(1.7毫微克/毫升),血浆LH浓度也出现了小幅但显著的升高。雌激素和睾酮均可抑制血浆LH水平,但反应存在明显差异。该免疫测定法在评估性腺功能减退的男性、育龄期闭经女性以及怀疑垂体功能减退的绝经后女性时,是一种有用的诊断工具。根据血浆中LH-(131)I的半衰期消失时间(平均69分钟)和计算出的分布容积(2.5 - 至2.8升),已确定男性每天分泌约30微克LH,女性除月经周期中期外也是如此,在月经周期中期,LH的释放估计是基础速率的10 - 15倍。